Accuracy of a Rapid Diagnostic Test for Cutaneous Leishmaniasis in Morocco
NCT ID: NCT02979002
Last Updated: 2017-08-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
219 participants
OBSERVATIONAL
2016-12-31
2017-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cutaneous Leishmaniasis Diagnostic Study
NCT03837431
Evaluation of a Rapid Diagnostic Device, CL Detect, for the Diagnosis of Cutaneous Leishmaniasis in Tunisia
NCT01769612
Evaluation of a Diagnostic Device, CL Detect™ Rapid Test, for the Diagnosis of Cutaneous Leishmaniasis in Peru
NCT03762070
Spatial Analysis of Host-parasite Interactions in Cutaneous Leishmaniasis in Ethiopia
NCT05332093
Human Leishmaniasis: Antigen Recognition Pattern and Study of New Potential Biomarkers
NCT06307171
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Who is able to learn the Information sheet and sign the Informed consent form by them selves or by their parents with the presence or not of a witness (for illiterate people)
* Who satisfy the following criteria :
* with an ulcerative lesion in any accessible part of the body to perform the dental broach and the scraping.
* Just one ulcerative lesion by patient could be selected (The newest and the less infected)
* Lesion should be less than 04 months of age
Exclusion Criteria
* Patients with ulcerative lesions with a suspected bacteria origin which could disappear after a short course of antibiotic treatment.
* Patients who already received during the last two months, prior to signing the consent, a physical treatment (e.g. cryotherapy, thermotherapy, Laser) or a traditional treatment (e.g. burn, acide, traditional scraping)
* Patients presenting other disease with the need to take anti-parasite treatments
* Patient with a acute or chronic disease needing hospitalization
* Patient who already received antimoniate treatment incomplete or complete duration and dose against CL
* Any situation that could engage the security of the patient or of the health professional (e.g. People with a psychiatric trouble or a mental handicap )
* For children less than 12 years old, the decision of participation is mainly based on the condition that their parents are able to learn and understand the information sheet and sign the informed consent form
5 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institute of Tropical Medicine, Belgium
OTHER
National School of Public Health, Morocco
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Issam Bennis, MD
Doctor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Issam Bennis, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
National School of Public Health - Rabat - Morocco
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Primary Health center
Arfoud, Errachidia, Morocco
Health primary center
Tinajdad, Errachidia, Morocco
Primary Health Center
Sekoura, Ouarzazates, Morocco
Primary Health Center
Tarmight, Ouarzazates, Morocco
Primary Health Center
Tazouta, Sefrou, Morocco
Primary Health Center
Boumalne Dades, Tinghir, Morocco
Primary Health Center
Kelaat Mgouna, Tinghir, Morocco
Primary Health Center
Sefrou, , Morocco
Primary Health Center
Sidi Kacem, , Morocco
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bennis I, Verdonck K, El Khalfaoui N, Riyad M, Fellah H, Dujardin JC, Sahibi H, Bouhout S, Van der Auwera G, Boelaert M. Accuracy of a Rapid Diagnostic Test Based on Antigen Detection for the Diagnosis of Cutaneous Leishmaniasis in Patients with Suggestive Skin Lesions in Morocco. Am J Trop Med Hyg. 2018 Sep;99(3):716-722. doi: 10.4269/ajtmh.18-0066. Epub 2018 Jul 5.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ENSP276/DGDB26012016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.